Utilizing Microbiome Approaches for Antibiotic Resistance Analysis; an Ocular Case Evaluation
Journal of Ophthalmic and Optometric Sciences,
Vol. 5 No. 1 (2021),
19 October 2022
,
Page 12-23
https://doi.org/10.22037/joos.v5i1.39242
Abstract
Background: Metaorganism or microbial communities of eukaryotic organisms provide an inclusive set of functions related to immunity, host metabolism, and stress tolerance. Ocular microbiota refers to pathogenic and commensal microorganisms in or on the eye. On the one hand, antibiotic treatment can give rise to pathogen overgrowth due to an imbalance of microbiota and cause various ophthalmic diseases. On the other, antibiotic therapy is considered the leading cause of antibiotic resistance. The present study aimed to describe the bacterial community changes following antibiotic treatment in the ocular surface microbiome.
Material and Methods: In this scenario, we evaluated the composition of thirteen canine ocular microbiomes during treatment with a typical mixture of antibiotics, neomycin-polymyxin-bacitracin. Microbiome taxonomy and downstream bacterial richness and evenness were analyzed using microbiome bioinformatics platforms.
Results: Accordingly, bacterial taxonomy at the level of phyla and genus was mapped, and alter of antibiotic resistance genes werereported. An increase in the Staphylococcus genus traced during the time and one month following antibiotic treatment. Bacterial network, alpha, and beta diversity indicated a significant microbiota change at the genus level.
Conclusion: This study highlights the effect of commonly used ocular antibiotics on commensal microbiota and the emergence of the antibiotic-resistant genus.
- Microbiota
- Antibiotic Resistance
- Ocular Microbiome
- Ophthalmic Diseases
How to Cite
References
Li JJ, Yi S, Wei L. Ocular microbiota and intraocular inflammation. Frontiers in Immunology. 2020;11:609765.
Rooks MG, Garrett WS. Gut microbiota, metabolites and host immunity. Nature reviews immunology. 2016;16(6):341-52.
Jakobsson HE, Jernberg C, Andersson AF, Sjölund-Karlsson M, Jansson JK, Engstrand L. Short-term antibiotic treatment has differing long-term impacts on the human throat and gut microbiome. PloS one. 2010;5(3):e9836.
Scott EM, Arnold C, Dowell S, Suchodolski JS. Evaluation of the bacterial ocular surface microbiome in clinically normal horses before and after treatment with topical neomycin-polymyxin-bacitracin. PLoS One. 2019;14(4):e0214877.
Berger R, Pappert A, Van Zile P, Cetnarowski W. A newly formulated topical triple-antibiotic ointment minimizes scarring. Cutis. 2000;65(6):401-4.
Youssef N, Sheik CS, Krumholz LR, Najar FZ, Roe BA, Elshahed MS. Comparison of species richness estimates obtained using nearly complete fragments and simulated pyrosequencing-generated fragments in 16S rRNA gene-based environmental surveys. Appl Environ Microbiol. 2009;75(16):5227–36.
Schloss PD, Westcott SL, Ryabin T, Hall JR, Hartmann M, Hollister EB, et al. Introducing mothur: Open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl Environ Microbiol. 2009;75(23):7537–41.
DeSantis TZ, Hugenholtz P, Larsen N, Rojas M, Brodie EL, Keller K, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Applied and environmental microbiology. 2006;72(7):5069-72.
Cole JR, Wang Q, Fish JA, Chai B, McGarrell DM, Sun Y, et al. Ribosomal Database Project: data and tools for high throughput rRNA analysis. Nucleic acids research. 2014;42(D1):D633-D42.
Overmann J, Abt B, Sikorski J. Present and Future of Culturing Bacteria. Annu Rev Microbiol. 2017;71:711–30.
Aragona P, Baudouin C, Del Castillo JMB, Messmer E, Barabino S, Merayo-Lloves J, et al. The ocular microbiome and microbiota and their effects on ocular surface pathophysiology and disorders. Survey of Ophthalmology. 2021;66(6):907-25.
PUBLICATION OF THE NATIONAL INTELLIGENCE COUNCIL. GLOBAL TRENDS 2040. 2021.
Bolyen E, Rideout JR, Dillon MR, Bokulich NA, Abnet CC, Al-Ghalith GA, et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nature biotechnology. 2019;37(8):852-7.
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: High-resolution sample inference from Illumina amplicon data. Nature methods. 2016;13(7):581-3.
Quast C, Pruesse E, Yilmaz P, Gerken J, Schweer T, Yarza P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic acids research. 2012;41(D1):D590-D6.
Snyder RW, Glasser DB. Antibiotic therapy for ocular infection. Western journal of medicine. 1994;161(6):579.
Steinmetz JD, Bourne RR, Briant PS, Flaxman SR, Taylor HR, Jonas JB, et al. Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. The Lancet Global Health. 2021;9(2):e144-e60.
O'Neill J. Tackling drug-resistant infections globally: final report and recommendations. 2016.
Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Aguilar GR, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629-55.
Ozkan J, Nielsen S, Diez-Vives C, Coroneo M, Thomas T, Willcox M. Temporal stability and composition of the ocular surface microbiome. Scientific reports. 2017;7(1):1-11.
Ozkan J, Willcox MD, Rathi VM, Srikanth D, Zhu H, de la Jara PL, et al. Effect of antibiotic drops on adverse events during extended lens wear. Optometry and Vision Science. 2014;91(1):13-23.
Dave SB, Toma HS, Kim SJ. Changes in ocular flora in eyes exposed to ophthalmic antibiotics. Ophthalmology. 2013;120(5):937-41.
de Kaspar HM, Hoepfner AS, Engelbert M, Thiel M, Ta CN, Mette M, et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology. 2001;108(3):470-8.
Bron PA, Van Baarlen P, Kleerebezem M. Emerging molecular insights into the interaction between probiotics and the host intestinal mucosa. Nature Reviews Microbiology. 2012;10(1):66-78.
George F, Daniel C, Thomas M, Singer E, Guilbaud A, Tessier FJ, et al. Occurrence and dynamism of lactic acid bacteria in distinct ecological niches: A multifaceted functional health perspective. Frontiers in microbiology. 2018;9:2899.
Zhang Y, Li C-X, Zhang X-Z. Bacteriophage-mediated modulation of microbiota for diseases treatment. Advanced Drug Delivery Reviews. 2021;176:113856.
- Abstract Viewed: 45 times
- pdf Downloaded: 72 times